1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Bing Xia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases Intestinal Low-Dose Radiotherapy (ILDR), PD-1/PD-L1 inhibitors, Combined Chemotherapy - Liver Metastases, Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Bing Xia | 120 | 2026-10-01 | 2026-10-15 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Disease (1)
Antineoplastic Combined Chemotherapy Protocols (1) · Immune Checkpoint Inhibitors (1) · Neoadjuvant Therapy (1) · Radiotherapy (1)
China (1)